Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01155583. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02119468. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
ClinicalTrials.gov study NCT05032820. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01478581. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ixazomib and Pevonedistat in Treating Patients With Multiple Myeloma That Has Come Back or Does Not Respond to Treatment
ClinicalTrials.gov study NCT03770260. IPD Sharing: YES. Countries: 1. Publications: 0.
Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT02168101. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.
ClinicalTrials.gov study NCT00325416. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Elranatamab in R/R Multiple Myeloma
ClinicalTrials.gov study NCT06138275. IPD Sharing: YES. Countries: 1. Publications: 0.
Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
ClinicalTrials.gov study NCT00439465. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study of Chinese Multiple Myeloma Patients Treated With Velcade
ClinicalTrials.gov study NCT01675245. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation
ClinicalTrials.gov study NCT02112045. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT02159365. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004)
ClinicalTrials.gov study NCT00109109. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
ClinicalTrials.gov study NCT04497961. IPD Sharing: YES. Countries: 1. Publications: 0.
Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma
ClinicalTrials.gov study NCT01177683. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients
ClinicalTrials.gov study NCT02843074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00540644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05565391. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice
ClinicalTrials.gov study NCT04659798. IPD Sharing: YES. Countries: 1. Publications: 0.
Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00366106. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.